Gangliosides: therapeutic agents or therapeutic targets?

This publication has 35 references indexed in Scilit:

• GM3 as a Novel Growth Regulator for Human Gliomas
  Experimental Neurology, 2001
• N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours
  British Journal of Cancer, 2001
• Selective Cell-Cycle Arrest and Induction of Apoptosis in Proliferating Neural Cells by Ganglioside GM3
  Experimental Neurology, 2001
• Neuroblastomas of infancy exhibit a characteristic ganglioside pattern
  Cancer, 2001
• Expression of GM3 microdomains on the surfaces of murine fibroblasts correlates with inhibition of cell proliferation.
  Histochemistry and Cell Biology, 2000
• GM₁ Ganglioside for Acute Ischemic Stroke: Trial Design Issues
  Annals of the New York Academy of Sciences, 1998
• GM1 Ganglioside: In Vivo and In Vitro Trophic Actions on Central Neurotransmitter Systems
  Journal of Neurochemistry, 1998
• Reovirus Receptors
  Published by Elsevier ,1993
• Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
  Proceedings of the National Academy of Sciences, 1985
• G _M1 Ganglioside Treatment Facilitates Behavioral Recovery from Bilateral Brain Damage
  Science, 1984